Prognostic Impact of Molecular Classification in High-Risk Endometrial Cancer - A Retrospective Study in an Indian Cohort.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 250
- 试验地点
- 1
研究概览
简要总结
Project Title: Prognostic Impact of Molecular Classification in High-Risk Endometrial Cancer - A Retrospective Study in an Indian Cohort. Endometrial cancer is a common cancer in women. While most cases are detected early and have good outcomes, some are high-risk and can behave aggressively. Recent studies have shown that molecular features of the tumor (such as POLE mutation, MMR deficiency, and p53 abnormality) can predict prognosis better than traditional methods. This retrospective study will analyze data of about 250 patients with high-risk endometrial cancer treated at Tata Memorial Centre between September 2019 and September 2025. Archived FFPE (Formalin-Fixed, Paraffin-Embedded tissue) tumor samples will be tested for molecular classification, and outcomes will be correlated with these subtypes. No new samples will be collected, and all data will be anonymized. There are no risks to participants, and findings may contribute to improving cancer care in the future.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)(—)
- 性别
- Female
入选标准
- •Histologically confirmed high-risk endometrial cancer
- •FIGO stage IB grade 3 and above
- •Stage II–III endometrioid carcinoma
- •Any stage serous or clear-cell carcinoma
- •Completion of primary surgery and adjuvant therapy
- •Availability of FFPE tissue.
排除标准
- •Low-risk endometrial cancer or missing critical clinical/tissue data
- •Recurrent/metastatic disease at initial presentation
- •Lost to follow-up within six months post-treatment.
研究者
Dr Anbarasan Sekar
Advanced Centre for Treatment, Research and Education in Cancer
